Editorial: anti‐TNF agents against vedolizumab as a second‐line treatment? Not surprising tie game—authors' reply.
Saved in:
| Title: | Editorial: anti‐TNF agents against vedolizumab as a second‐line treatment? Not surprising tie game—authors' reply. |
|---|---|
| Authors: | Rundquist, Sara1 (AUTHOR) sara.rundquist@regionorebrolan.se, Sachs, Michael C.2 (AUTHOR), Eriksson, Carl1,2 (AUTHOR), Olén, Ola2,3 (AUTHOR), Montgomery, Scott2,4 (AUTHOR), Halfvarson, Jonas1 (AUTHOR) |
| Source: | Alimentary Pharmacology & Therapeutics. Mar2021, Vol. 53 Issue 5, p642-643. 2p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 02692813 |
|---|---|
| DOI: | 10.1111/apt.16241 |
